Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Valacchi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Chemical Communications (Cambridge, England)|July 18, 2002
Base promoted isomerization of aziridinyl ethers: a new access to alpha- and beta-amino acidsAlessandro Mordini, Laura Sbaragli, Michela Valacchi, et al.
The Journal of Organic Chemistry|October 24, 2001
A Selective Access to Amino Hydroxy OxetanesAlessandro Mordini, Michela Valacchi, Chiara Nardi, et al.
Journal of Medicinal Chemistry|April 4, 2012
Discovery of a novel alpha-7 nicotinic acetylcholine receptor agonist series and characterization of the potent, selective, and orally efficacious agonist 5-(4-acetyl[1,4]diazepan-1-yl)pentanoic acid [5-(4-methoxyphenyl)-1H-pyrazol-3-yl] amide (SEN15924, WAY-361789)Riccardo Zanaletti, Laura Bettinetti, Cristiana Castaldo, et al.
Bioorganic & Medicinal Chemistry|June 12, 2009
SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonistSimon N Haydar, Chiara Ghiron, Laura Bettinetti, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin ToxicitySalvatore La Rosa, Tiziana Benicchi, Laura Bettinetti, et al.
Journal of Medicinal Chemistry|October 23, 2012
N-[5-(5-fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): a medicinal chemistry effort toward an α7 nicotinic acetylcholine receptor agonist preclinical candidateRiccardo Zanaletti, Laura Bettinetti, Cristiana Castaldo, et al.
Journal of Medicinal Chemistry|May 15, 2010
Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914)Chiara Ghiron, Simon N Haydar, Suzan Aschmies, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|July 18, 2002
Base promoted isomerization of aziridinyl ethers: a new access to alpha- and beta-amino acidsAlessandro Mordini, Laura Sbaragli, Michela Valacchi, et al.
The Journal of Organic Chemistry|October 24, 2001
A Selective Access to Amino Hydroxy OxetanesAlessandro Mordini, Michela Valacchi, Chiara Nardi, et al.
Journal of Medicinal Chemistry|April 4, 2012
Discovery of a novel alpha-7 nicotinic acetylcholine receptor agonist series and characterization of the potent, selective, and orally efficacious agonist 5-(4-acetyl[1,4]diazepan-1-yl)pentanoic acid [5-(4-methoxyphenyl)-1H-pyrazol-3-yl] amide (SEN15924, WAY-361789)Riccardo Zanaletti, Laura Bettinetti, Cristiana Castaldo, et al.
Bioorganic & Medicinal Chemistry|June 12, 2009
SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonistSimon N Haydar, Chiara Ghiron, Laura Bettinetti, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin ToxicitySalvatore La Rosa, Tiziana Benicchi, Laura Bettinetti, et al.
Journal of Medicinal Chemistry|October 23, 2012
N-[5-(5-fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): a medicinal chemistry effort toward an α7 nicotinic acetylcholine receptor agonist preclinical candidateRiccardo Zanaletti, Laura Bettinetti, Cristiana Castaldo, et al.
Journal of Medicinal Chemistry|May 15, 2010
Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914)Chiara Ghiron, Simon N Haydar, Suzan Aschmies, et al.
Pageof 1